Zydus Wellness Limited (IN:ZYDUSWELL)
:ZYDUSWELL
ZYDUSWELL Stock Chart & Stats
₹424.90
-₹21.60(-1.10%)
At close: 4:00 PM EST
₹424.90
-₹21.60(-1.10%)
Day’s Range― - ―
52-Week Range₹321.24 - ₹530.55
Previous CloseN/A
Volume6.77K
Average Volume (3M)15.16K
Market Cap
₹155.53B
Enterprise Value₹60.37B
Total Cash (Recent Filing)₹1.48B
Total Debt (Recent Filing)₹30.42B
Price to Earnings (P/E)―
Beta0.79
Next Earnings
May 19, 2026EPS Estimate
5.13Next Dividend Ex-DateN/A
Dividend Yield0.28%
Share Statistics
EPS (TTM)-1.30
Shares Outstanding318,160,700
10 Day Avg. Volume9,092
30 Day Avg. Volume15,161
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)0.38
Price to Sales (P/S)0.79
P/FCF Ratio6.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)13.24
Revenue Forecast (FY)₹52.58B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained top-line growth indicates broad-based demand and effective brand penetration across channels. Over a 2-6 month horizon this underpins scale advantages in distribution and marketing, supporting reinvestment capacity and resilience against single-channel volatility.
Very Low LeverageMinimal financial leverage reduces interest burden and increases financial flexibility. With low debt, the company can allocate cash to brand building, capex or M&A without heavy refinancing risk, improving long-term stability and ability to withstand cyclical demand shocks.
Healthy Margins & Cash GenerationRobust gross and net margins combined with rising free cash flow create durable internal funding for marketing and innovation. Strong cash conversion supports operational continuity and strategic investments, reducing reliance on external capital and preserving margin cushions against input cost swings.
Bears Say
Declining EPSA sharp decline in EPS signals pressure on per-share profitability that can persist if structural cost or mix issues remain. Over months this can constrain retained earnings growth, limit dividend flexibility, and reduce internal funding available for brand and distribution expansion.
Gross Margin PressureA falling gross margin suggests input cost or pricing pressures that could erode profitability if sustained. For an FMCG/FMCH player, prolonged margin compression reduces ability to fund marketing and trade spend, harming competitive positioning and long-term margin sustainability.
Moderate Return On EquityA mid-single-digit ROE implies limited capital efficiency relative to higher-return peers. Persistently moderate ROE can signal weaker long-term shareholder value creation, constraining the firm's ability to attract capital and justify premium reinvestment for faster growth.
Zydus Wellness Limited News
ZYDUSWELL FAQ
What was Zydus Wellness Limited’s price range in the past 12 months?
Zydus Wellness Limited lowest stock price was ₹321.24 and its highest was ₹530.55 in the past 12 months.
What is Zydus Wellness Limited’s market cap?
Zydus Wellness Limited’s market cap is ₹155.53B.
When is Zydus Wellness Limited’s upcoming earnings report date?
Zydus Wellness Limited’s upcoming earnings report date is May 19, 2026 which is in 38 days.
How were Zydus Wellness Limited’s earnings last quarter?
Zydus Wellness Limited released its earnings results on Feb 03, 2026. The company reported -₹1.3 earnings per share for the quarter, missing the consensus estimate of ₹0.3 by -₹1.6.
Is Zydus Wellness Limited overvalued?
According to Wall Street analysts Zydus Wellness Limited’s price is currently Overvalued.
Does Zydus Wellness Limited pay dividends?
Zydus Wellness Limited pays a Annually dividend of ₹1.2 which represents an annual dividend yield of 0.28%. See more information on Zydus Wellness Limited dividends here
What is Zydus Wellness Limited’s EPS estimate?
Zydus Wellness Limited’s EPS estimate is 5.13.
How many shares outstanding does Zydus Wellness Limited have?
Zydus Wellness Limited has 318,160,700 shares outstanding.
What happened to Zydus Wellness Limited’s price movement after its last earnings report?
Zydus Wellness Limited reported an EPS of -₹1.3 in its last earnings report, missing expectations of ₹0.3. Following the earnings report the stock price went down -3.943%.
Which hedge fund is a major shareholder of Zydus Wellness Limited?
Currently, no hedge funds are holding shares in IN:ZYDUSWELL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zydus Wellness Limited
Zydus Wellness Limited develops, produces, markets, and distributes health and wellness products in India. It provides sugar substitute products under the Sugar Free Gold, Sugar Free Natura, and Sugar Free Green brands; milk-based health food drink under the Complan brand; glucose-based beverage under the Glucon D brand; and Sugarlite, a blended sugar coated with stevia. The company also offers a range of skincare products, such as soap-free face washes, face masks, scrubs, and cleansers under the Everyuth brand; prickly heat and cooling powder, and hand sanitizer under the Nycil brand; and probiotic butter spread, table spread, ghee, butter, cholesterol fat-free spread, mayonnaise, and chocolate spread under the Nutralite brand. In addition, it exports its products. The company was formerly known as Carnation Nutra Analogue Foods Limited and changed its name to Zydus Wellness Limited in January 2009. The company was founded in 1988 and is based in Ahmedabad, India. Zydus Wellness Limited is a subsidiary of Cadila Healthcare Limited.
Technical Analysis
Mrs. Bector's Food Specialities Ltd.
―
Bikaji Foods International Ltd.
―
Fine Organic Industries Ltd.
―
Jyothy Labs Limited
―
Pearl Global Industries Limited
―